Blue Goat CyberBlue Goat CyberSMMedical Device Cybersecurity
    All infographics
    Working with Blue Goat

    Cybersecurity due diligence for medtech investors

    What an investor diligence review delivers: a one-page summary in about 2 weeks, from $7,500, under NDA.

    Infographic with a fictional one-page executive summary showing an FDA readiness verdict, five rated findings, and a gap-closing estimate, beside three facts: about 2 weeks, from $7,500, and NDA signed first.
    The sample uses a fictional company. Real reports include full written findings behind the summary.
    Download the graphicTalk through it with us

    What the graphic says

    The full text version, so the content is readable without the image.

    The facts

    Turnaround
    About 2 weeks.
    Price
    From $7,500, fixed fee.
    Confidentiality
    We sign an NDA before seeing any documents.

    Sample summary (fictional)

    Company
    NeuroLoop Medical, a made-up company.
    Verdict
    Not ready for the planned filing date; expected slip about 3 to 4 months.
    Findings
    High: threat model skips app and cloud. High: no pen test scheduled. Medium: 9 SBOM components with known issues. Medium: firmware updates not signed. Low: postmarket plan is a draft.
    Gap-closing estimate
    $60,000 to $90,000.

    Keep reading

    More in Working with Blue Goat

    Ready when you are

    Get FDA cleared without the cybersecurity headaches.

    30-minute strategy session. No cost, no commitment - just answers from people who've shipped 275+ devices supported.

    Book strategy sessionExplore services